» Articles » PMID: 19549579

Infections in Patients with Aplastic Anemia

Overview
Journal Semin Hematol
Specialty Hematology
Date 2009 Jun 25
PMID 19549579
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Infection is a major cause of death in patients with aplastic anemia (AA). There are differences between the immunocompromised state of a patient with AA and the patient who is neutropenic due to chemotherapy and this leads to a difference in the infections that they incur. Prolonged neutropenia is one of the largest risk factors for the development of infections with the invasive mycoses and bacteria. Recovery from neutropenia is directly related to survival, and supportive care plays a large role in protection while the patient is in a neutropenic state. The most common invasive mycoses include the Aspergillus species, Zygomycetes, Candida spp., and Fusarium spp. Bacterial infections that are seen in patients with AA include gram-positive coagulase-negative Staphylococcus species, Enterococcus, Staphylococus aureus, Clostridium spp., Micrococcus, alpha-hemolytic streptococci, Listeria monocytogenes, and Bacillus cereus. Gram-negative infections including gram-negative bacilli, Escherichia coli, Salmonella, Bacteroides fragilis, Klebsiella oxytoca, Klebsiella pneumonia, Aeromonas hydrophilia, Pseudomonas aeruginosa, and Vibrio vulnificus. Viral infections are much less common but include those that belong to the Herpesviridae family, community-acquired respiratory viral infection, and the viral hepatitides A, B, and C. Evidence of the parasite Strongyloides stercoralis has also been documented. This review discusses the major invasive fungal infections, bacterial pathogens, parasites, and viral infections that are found in patients with AA who are treated with immunosuppressive therapy. The specific immune impairment and current treatment parameters for each of these classes of infection will also be discussed.

Citing Articles

Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events.

Saelue P, Penthinapong T Infect Chemother. 2024; 56(4):483-491.

PMID: 39431342 PMC: 11704865. DOI: 10.3947/ic.2024.0045.


Rapid diagnosis of infection in acute very severe aplastic anemia with metagenomic next-generation sequencing: a case report and literature review.

Kang Y, Zhang X, Qin C, Zheng Y, Gai W, Jia X Front Med (Lausanne). 2024; 11:1413964.

PMID: 39376649 PMC: 11456449. DOI: 10.3389/fmed.2024.1413964.


Successful Treatment of Severe Aplastic Anemia with Hematopoietic Stem Cell Transplantation in the Setting of Active Mucormycosis.

Zhumatayev S, Celen S, Kara M, Selcuk A, Bozkurt B, Demir M Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3552-3555.

PMID: 39130341 PMC: 11306456. DOI: 10.1007/s12070-024-04610-1.


Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia.

Prabahran A, Durrani J, Coelho-Da Silva J, Shalhoub R, Lotter J, Rios O Br J Haematol. 2024; 205(3):1170-1179.

PMID: 39021060 PMC: 11499006. DOI: 10.1111/bjh.19648.


Unrelated umbilical cord blood transplantation with low-dose anti-thymocyte globulin for children with severe aplastic anemia: A case series.

Hu M, Li J, Liu R, Zhang Z, Feng S, Zhong D Ann Hematol. 2024; 103(6):2103-2111.

PMID: 38656370 DOI: 10.1007/s00277-024-05756-2.